15
Participants
Start Date
January 6, 2017
Primary Completion Date
September 1, 2019
Study Completion Date
October 8, 2019
Glucose infusion
Infusion of 20% dextrose (drug) and using this as an imaging tracer in detecting and staging tumours.
Magnetic Resonance Imaging (MRI)
MRI scanners (device) use strong magnetic fields, radio waves, and field gradients to generate images of the organs in the body. Specifically using the MRI scanner with the infusion of dextrose in detecting and staging tumours.
FDG PET
FDG is a sugar (glucose) labelled with a small amount of radioactivity which goes to parts of the body that use glucose for energy. PET/CT images are acquired on a single scanner. An FDG PET scan can be used to assess the presence, location and severity of cancers.
University College London Hospital, London
Collaborators (1)
University College, London
OTHER
Cancer Research UK
OTHER